Alun Bermingham

Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530

Tim P. Green, Mike Fennell, Robin Whittaker et al. · Molecular Oncology · 2009 · 256 citations · Full text

Medicine, Oncology, Pharmacology +10

Prevention of MKK6-Dependent Activation by Binding to p38α MAP Kinase

Jane E. Sullivan, Geoffrey A. Holdgate, Douglas A. Campbell et al. · Biochemistry · 2005 · 90 citations

Life Sciences, Molecular Biology, Pharmacology +16

Vinylogous Ureas as a Novel Class of Inhibitors of Reverse Transcriptase-Associated Ribonuclease H Activity

Michaela Wendeler, Hsiu-Fang Lee, Alun Bermingham et al. · ACS Chemical Biology · 2008 · 61 citations · Full text

Life Sciences, Biochemistry, Medicinal Chemistry +16

Optimization of novel monobactams with activity against carbapenem-resistant Enterobacteriaceae – Identification of LYS228

Folkert Reck, Alun Bermingham, Johanne Blais et al. · Bioorganic & Medicinal Chemistry Letters · 2018 · 58 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

Structure-Activity Analysis of Vinylogous Urea Inhibitors of Human Immunodeficiency Virus-Encoded Ribonuclease H

Suhman Chung, Michaela Wendeler, Jason W. Rausch et al. · Antimicrobial Agents and Chemotherapy · 2010 · 47 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16